1-(2-噻唑)-3-(8-(5-对磺酸基苯基偶氮)喹啉)-三氮烯的合成及其与铜(Ⅱ)的显色反应

合成了新试剂1-(2-噻唑)-3-(8-(5-对磺酸基苯基偶氮)喹啉-三氮烯(TCPQT),并研究了其与Cu2+的显色反应。结果表明:在pH 7.5的磷酸盐缓冲溶液中,TCPQT与Cu2+形成摩尔比为1:1的紫红色络合物,该络合物在606.5nm处有一最大吸收峰,其表观摩尔吸光系数为3.36×105L.mol-1.cm-1,Cu2+的质量浓度在0～0.4μg/mL范围内符合比尔定律,相关系数r=0.9993。方法已用于测定食品中的微量铜。     

邻溴苯胺/丙烯醛Schiff碱分子内Heck反应——合成喹啉的新方法

探讨了一种以邻溴苯胺和丙烯醛为原料合成喹啉的新方法,对反应条件进行了优化,并利用质谱和红外光谱分析确认了合成产物的结构.结果表明,以邻溴苯胺和丙烯醛为原料,经2步反应可得到喹啉:首先,邻溴苯胺和丙烯醛反应生成Schiff碱;随后,Schiff碱在催化剂和N2保护下经分子内Heck反应形成目标产物(总产率为45.1%).该合成方法具有操作简单、易于控制、催化剂可重复使用等优点.     

纳米二氧化钛光催化降解喹啉动力学

利用溶胶-凝胶法制备纳米二氧化钛光催化剂,探讨了其光催化降解废水中典型含氮杂环化合物喹啉的动力学行为。实验条件下,TiO₂光催化降解喹啉的反应为准一级反应,可用Langmuir-Hinshelwood动力学模型描述,其表达式为r=0.296kc_t/(1+0.296c_t),其中,lnk =-0.411 1lnc₀+2.278。     

Synthesis,design, and antimicrobial activity of pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidinones based on quinoline derivatives

The pyrido[2,3-d]pyrimidine moieties are one of the most biologically widespread heterocyclic compounds as antimicrobial, antioxidant, antitubercular, antiviral and anti-inflammatory. Hence, we synthesized an efficient new series of 2-thioxo-pyrido[2,3-d]pyrimidinone, 2-hydrazinyl-(quinolin-2-yl)pyrido[2,3-d]pyrimidinone,N′-(quinolin-2-yl)-pyrido[2,3-d]pyrimidine-(formo/aceto)-hydrazide and substituted-(quinolin-2-yl)pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidinone derivatives. The characterization of new compounds was corresponded by using spectroscopic techniques, IR, NMR and Mass spectra. In vitro, all compounds were evaluated as antimicrobial activity compared with cefotaxime sodium and nystatin as the standard drug. This work deals with the exploration of the new heterocyclic compounds and medicinal diversity of quinoline-pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidine derivatives that might pave the way for long in the discovery of therapeutic medicine for future drug design.     

水介质中1,4-二芳基喹啉-2,5-二酮衍生物的绿色合成

以芳醛、3-芳氨基-5,5-二甲基环己-2-烯酮和Meldrum酸为原料, 以水为溶剂, 在回流条件下以三乙基苄基氯化铵为催化剂通过三组分一步反应, 合成了一系列的7,7-二甲基-1,4-二芳基-1,2,3,4,5,6,7,8-八氢化喹啉-2,5-二酮衍生物. 该方法具有中性反应条件、产率高(80 %～92 %)、操作简单和环境友好等优点.     

Synthesis and positive inotropic evaluation of 1-(benzylamino)-3-(4,5-di-hydro[1,2,4]trizaolo[4,3-a]quinolin-7-yloxy)propan-2-ol derivatives

In an attempt to search for more potent positive inotropic agents,a series of 1-(benzylamino)-3-(4,5-dihydro[1,2,4]trizaolo[4,3- a]quinolin-7-yloxy)propan-2-ol derivatives was synthesized in four steps using 6-hydroxy-3,4-dihydro-2(1H)-quinolinone as a starting material,and their positive inotropic activities were evaluated by measuring the coronary blood flow(CBF)and the left ventricular pressure(LVP)followed by calculating the rate of pressure development(dp/dt_(max)values)in the preparation of rat Lan...     

Theoretical prediction of Ni(I)-catalyst for hydrosilylation of pyridine and quinoline

Catalytic synthesis of dihydropyridine by transition-metal complex is one of the important research targets, recently. Density functional theory calculations here demonstrate that nickel(I) hydride complex (bpy)Ni^IH (bpy = 2,2′-bipyridine) 1 is a good catalyst for hydrosilylation of both quinoline and pyridine. Two pathways are possible; in path 1, substrate reacts with 1 to form stable intermediate Int1 . After that, N³─C¹ bond of substrate inserts into Ni─H bond of 1 via TS1 to afford N-coordinated 1,2-dihydroquinoline Int2 with the Gibbs activation energy (ΔG°^‡) of 21.8 kcal mol⁻¹. Then, Int2 reacts with hydrosilane to form hydrosilane σ-complex Int3 ; this is named path 1A. In the other route (path 1B), Int1 reacts with phenylsilane in a concerted manner via hydride-shuttle transition state TS2 to afford Int3 . In TS2 , Si atom takes hypervalent trigonal bipyramidal structure. Formation of hypervalent structure is crucial for stabilization of TS2 (ΔG°^‡ = 17.3 kcal mol⁻¹). The final step of path 1 is metathesis between Ni─N³ bond of Int3 and Si─H bond of PhSiH₃ to afford N-silylated 1,2-dihydroproduct and regenerate 1 (ΔG°^‡ = 4.5 kcal mol⁻¹). In path 2, 1 reacts with hydrosilane to form Int5 , which then forms adduct Int6 with substrate through Si–N interaction between substrate and PhSiH₃. Then, N-silylated 1,2-dihydroproduct is produced via hydride-shuttle transition state TS5 (ΔG°^‡ = 18.8 kcal mol⁻¹). The absence of N-coordination of substrate to Ni^I in TS5 is the reason why path 2 is less favorable than path 1B. Quinoline hydrosilylation occurs more easily than pyridine because quinoline has the lowest unoccupied molecular orbital at lower energy than that of pyridine. © 2019 Wiley Periodicals, Inc.     

An efficient heterogeneous gold(I)-catalyzed intermolecular cycloaddition of 2-aminoaryl carbonyls and internal alkynes leading to polyfunctionalized quinolines

The first heterogeneous intermolecular cycloaddition of 2-aminoaryl carbonyls and internal alkynes was realized in DMF at 100?°C by using a triphenylphosphine-functionalized MCM-41-supported gold(I) complex [MCM-41-PPh₃-AuCl] and AgOTf as catalysts, yielding a variety of polyfunctionalized quinolines in good to excellent yields. This heterogeneous gold(I) complex could easily be prepared via a simple two-step procedure from commercially available reagents and recovered by filtration of the reaction mixture. The recovered catalyst could be reused at least seven times with almost consistent activity without addition of AgOTf as a cocatalyst.     

Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer’s Disease‒Synthesis,In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the leading cause of dementia worldwide. The limited pharmacological approaches based on cholinesterase inhibitors only provide symptomatic relief to AD patients. Moreover, the adverse side effects such as nausea, vomiting, loss of appetite, muscle cramps, and headaches associated with these drugs and numerous clinical trial failures present substantial limitations on the use of medications and call for a detailed insight of disease heterogeneity and development of preventive and multifactorial therapeutic strategies on urgent basis. In this context, we herein report a series of quinoline-thiosemicarbazone hybrid therapeutics as selective and potent inhibitors of cholinesterases. A facile multistep synthetic approach was utilized to generate target structures bearing multiple sites for chemical modifications and establishing drug-receptor interactions. The structures of all the synthesized compounds were fully established using readily available spectroscopic techniques (FTIR, ¹H- and ¹³C-NMR). In vitro inhibitory results revealed compound 5b as a promising and lead inhibitor with an IC₅₀ value of 0.12 ± 0.02 μM, a 5-fold higher potency than standard drug (galantamine; IC₅₀ = 0.62 ± 0.01 μM). The synergistic effect of electron-rich (methoxy) group and ethylmorpholine moiety in quinoline-thiosemicarbazone conjugates contributes significantly in improving the inhibition level. Molecular docking analysis revealed various vital interactions of potent compounds with amino acid residues and reinforced the in vitro results. Kinetics experiments revealed the competitive mode of inhibition while ADME properties favored the translation of identified inhibitors into safe and promising drug candidates for pre-clinical testing. Collectively, inhibitory activity data and results from key physicochemical properties merit further research to ensure the design and development of safe and high-quality drug candidates for Alzheimer’s disease.     

偶氮喹啉双重光谱响应识别氟离子

8-羟基喹啉-5-偶氮-4'-对二甲氨基苯(1)在乙腈中发射双重荧光,其波长分别为512 nm和370 nm,加入F-后,长波处的荧光猝灭,短波处的荧光增强.同时1的吸收光谱和溶液颜色均发生明显变化.结果表明1通过氢键作用与F-形成了1:1型配合物,结合常数为5.0×104 mol-1·L,其它阴离子的存在均不影响1的吸收光谱和荧光光谱,表明1对F-有很高的选择性.据此建立了荧光比值法与裸眼比色法检测F-的方法.